Elanco Animal Health Inc (NYSE:ELAN)

23.86
Delayed Data
As of May 27
 +0.14 / +0.59%
Today’s Change
20.51
Today|||52-Week Range
37.49
-15.93%
Year-to-Date
SECTOR
Process Industries
INDUSTRY
Agricultural Commodities/Milling
MARKET CAP
$11.5B

Company Description

Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants &

Contact Information

Elanco Animal Health, Inc.
2500 Innovation Way
Greenfield Indiana 46140
P:(877) 352-6261
Investor Relations:

Employees

Shareholders

Individual stakeholders63.14%
Mutual fund holders54.73%
Other institutional46.70%

Top Executives

Jeffrey N. SimmonsPresident, Chief Executive Officer & Director
Todd S. YoungChief Financial Officer & Executive Vice President
Christopher KeeleyChief Information Officer & Senior Vice President
Ramiro M. CabralExecutive VP & President-Elanco International
Marcela A. KirbergerSecretary, Executive VP & General Counsel